Lv1
20 积分 2022-12-09 加入
50 years of Progress in Non-Small Cell Lung Cancer: A New Fellow’s Guide in the Clinic
8小时前
待确认
Lung cancer
1天前
已完结
Correction to abstract title “Efficacy and safety of [177Lu]Lu‐edotreotide vs. everolimus in patients with grade 1 or grade 2 gastroenteropancreatic neuroendocrine tumours: COMPETE phase 3 trial”
17天前
已完结
Antibodies to watch in 2025
1个月前
已完结
Antibody–Drug Conjugates: Pharmacokinetic/Pharmacodynamic Modeling, Preclinical Characterization, Clinical Studies, and Lessons Learned
1个月前
已完结
Expression profiles of cadherin 17 and claudin 18.2 in comparison with peptide hormonal expression in pancreatic neuroendocrine tumours: Implications for targeted immunotherapy
1个月前
已完结
Claudin 18.2 as a novel therapeutic target
1个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
皖公网安备34019202002308
